InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,099.51
(
1.01%
)
US TECH 100
17,240.80
(
1.55%
)
Dow Jones
38,210.24
(
0.33%
)
Brent Oil
88.34
(
0.21%
)
Bitcoin
63,420.52
(
-1.65%
)
Post# of 3061
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Whos_Who

Send PM Follow Ignore
Followers 15
Posts 1122
Boards Moderated 0
Alias Born 07/28/2014

Whos_Who

Re: None

Monday, 04/02/2018 2:37:12 PM

Monday, April 02, 2018 2:37:12 PM

Post# of 3061
Main catalysts for BPMX (including 16 pending patents):

Fiscal year Q2 (May, June, July 2018)

*Commercial partnership*

Phase 3 for BPX-01 for acne.

Initiation of phase 2 study of BPX- 04 for rosacea.

Submission of new product candidate to FDA
2H 2018

Complete phase 2 enrollment of BPX-04 for rosacea.

Advance preclinical candidate into clinic
Phase 3 program ready to initiate for BPX-01 for acne
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up